iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability

Fei Gao1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong;2 Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen;3 College of Pharmacy, Chengdu University of Chinese Medicine, Chengdu

Jinming Zhang3 College of Pharmacy, Chengdu University of Chinese Medicine, Chengdu

Chaomei Fu3 College of Pharmacy, Chengdu University of Chinese Medicine, Chengdu

Xiaoming Xie4 Department of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine

Fu Peng1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong;2 Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen;3 College of Pharmacy, Chengdu University of Chinese Medicine, Chengdu

Jieshu You1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong;2 Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen

Hailin Tang1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong;2 Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen;4 Department of Breast Oncology, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine

Zhiyu Wang5 Department of Mammary Disease, Guangdong Provincial Hospital of Chinese Medicine, Guangzhou

Peng Li6 State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Macau, People’s Republic of China

Jianping Chen1 School of Chinese Medicine, Li Ka Shing Faculty of Medicine, University of Hong Kong, Hong Kong;2 Shenzhen Institute of Research and Innovation, University of Hong Kong, Shenzhen;3 College of Pharmacy, Chengdu University of Chinese Medicine, ChengduCorrespondence[email protected]

show all

iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

iRGD-modified lipid–polymer hybrid nanoparticles loaded with isoliquiritigenin to enhance anti-breast cancer effect and tumor-targeting ability

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date